Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Endocrinological Investigation
Erschienen in: Journal of Endocrinological Investigation 2/2015

01.02.2015 | Consensus Statement

Rare diseases in clinical endocrinology: a taxonomic classification system

verfasst von: G. Marcucci, L. Cianferotti, P. Beck-Peccoz, M. Capezzone, F. Cetani, A. Colao, M. V. Davì, E. degli Uberti, S. Del Prato, R. Elisei, A. Faggiano, D. Ferone, C. Foresta, L. Fugazzola, E. Ghigo, G. Giacchetti, F. Giorgino, A. Lenzi, P. Malandrino, M. Mannelli, C. Marcocci, L. Masi, F. Pacini, G. Opocher, A. Radicioni, M. Tonacchera, R. Vigneri, M. C. Zatelli, M. L. Brandi

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Rare endocrine–metabolic diseases (REMD) represent an important area in the field of medicine and pharmacology. The rare diseases of interest to endocrinologists involve all fields of endocrinology, including rare diseases of the pituitary, thyroid and adrenal glands, paraganglia, ovary and testis, disorders of bone and mineral metabolism, energy and lipid metabolism, water metabolism, and syndromes with possible involvement of multiple endocrine glands, and neuroendocrine tumors. Taking advantage of the constitution of a study group on REMD within the Italian Society of Endocrinology, consisting of basic and clinical scientists, a document on the taxonomy of REMD has been produced.

Methods and results

This document has been designed to include mainly REMD manifesting or persisting into adulthood. The taxonomy of REMD of the adult comprises a total of 166 main disorders, 338 including all variants and subtypes, described into 11 tables.

Conclusions

This report provides a complete taxonomy to classify REMD of the adult. In the future, the creation of registries of rare endocrine diseases to collect data on cohorts of patients and the development of common and standardized diagnostic and therapeutic pathways for each rare endocrine disease is advisable. This will help planning and performing intervention studies in larger groups of patients to prove the efficacy, effectiveness, and safety of a specific treatment.
Literatur
1.
2.
3.
Institute of Medicine (2010) Rare diseases and orphan products: accelerating research and development. The National Academies Press, Washington DC
4.
5.
6.
7.
8.
9.
Griggs RC, Batshaw M, Dunkle M, Gopal-Srivastava R, Kaye E, Krischer J, Nguyen T, Paulus K, Merkel PA, Rare Diseases Clinical Research Network (2009) Clinical research for rare disease: opportunities, challenges, and solutions. Mol Genet Metab 96:20–26PubMedCentralPubMed
10.
5th European Conference on rare Diseases European reference networks and Center of Expertise for rare Diseases (2010) pp 1–75
11.
Office of Rare Disease Research. Global rare disease patient registry and data repository background. (2013) [cited 2013 March 1]
12.
Daneshvari S, Youssof S, Kroth PJ (2013) The NIH Office of Rare Diseases Research Patient Registry Standard: a report from the University of New Mexico’s Oculopharyngeal Muscular Dystrophy Patient Registry: AMIA Annu Symp Proc 269–277
13.
Bellgard M, Beroud C, Parkinson K, Harris T, Ayme S, Baynam G, Weeramanthri T, Dawkins H, Hunter A (2014) Correction: dispelling myths about rare disease registry system development. Source Code Biol Med 9:4PubMedCentralPubMed
14.
Landais P, Messiaen C, Rath A, Le Mignot L, Dufour E, Ben Said M, Jais JP, Toubiana L, Baujat G, Bourdon-Lanoy E, Gérard-Blanluet M, Bodemer C, Salomon R, Aymé S, Le Merrer M, Verloes A (2010) CEMARA task force. CEMARA an information system for rare diseases. Stud Health Technol Inform 160:481–485PubMed
15.
Aymé S, Rodwell C (2014) The European Union Committee of Experts on Rare Diseases: three productive years at the service of the rare disease community. Orphanet J Rare Dis 9:30PubMedCentralPubMed
16.
Aymé S, Kole A, Groft S (2008) Empowerment of patients: lessons from the rare diseases community. Lancet 371:2048–2051PubMed
17.
Kole A, Faurisson F (2010) Rare diseases social epidemiology: analysis of inequalities. Adv Exp Med Biol 686:223–250PubMed
18.
Taru Taruscio D, Gentile AE, De Santis M, Ferrelli RM, Posada de la Paz M, Hens M, Huizer J, Fregonese L, Stefanov R, Bottarelli V, Weinman A, Le Cam Y, Gavhed D, Mincarone P, Bushby K, Frazzica RG, Donati C, Vittozzi L, Jessop E (2013) EUROPLAN: a project to support the development of national plans on rare diseases in Europe. Public Health Genomics 16:278–287
19.
20.
Pastores GM, Gupta P (2013) Orphan drug development. Pediatr Endocrinol Rev 11:64–67PubMed
21.
Hamosh A, Scott AF, Amberger J, Valle D, McKusick VA (2000) Online Mendelian inheritance in man (OMIM). Hum Mutat 15:57–61PubMed
22.
Gray KA, Daugherty LC, Gordon SM, Seal RL, Wright MW, Bruford EA (2013) Genenames.org: the HGNC resources in 2013. Nucleic Acids Res 41:D545–D552PubMedCentralPubMed
23.
Rath A, Olry A, Dhombres F, Brandt MM, Urbero B, Ayme S (2012) Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users. Hum Mutat 33:803–808PubMed
24.
Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J, Vance ML, Ho K, Giustina A, Acromegaly Consensus Group (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94:1509–1517PubMed
25.
Beck-Peccoz P, Persani L, Mannavola D, Campi I (2009) Pituitary tumours: TSH-secreting adenomas. Best Pract Res Clin Endocrinol Metab 23:597–606PubMed
26.
27.
Chanson P, Brochier S (2005) Non-functioning pituitary adenomas. J Endocrinol Invest 28:93–99PubMed
28.
Dahlqvist P, Koskinen LO, Brännström T, Hägg E (2010) Testicular enlargement in a patient with a FSH-secreting pituitary adenoma. Endocrine 37:289–293PubMed
29.
Martucci F, Trivellin G, Korbonits M (2012) Familial isolated pituitary adenomas: an emerging clinical entity. J Endocrinol Invest 11:1003–1014
30.
Mitchell AL, Dwyer A, Pitteloud N, Quinton R (2011) Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory. Trends Endocrinol Metab 22:249–258PubMed
31.
Moore SJ, Green JS, Fan Y, Bhogal AK, Dicks E, Fernandez BA, Stefanelli M, Murphy C, Cramer BC, Dean JC, Beales PL, Katsanis N, Bassett AS, Davidson WS, Parfrey PS (2005) Clinical and genetic epidemiology of Bardet–Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study. Am J Med Genet A 132:352–360PubMedCentral
32.
Feigerlová E, Diene G, Oliver I, Gennero I, Salles JP, Arnaud C, Tauber M (2010) Elevated insulin-like growth factor-I values in children with Prader–Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment. J Clin Endocrinol Metab 95:4600–4608PubMed
33.
Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, Carey C, Macdermott S, Russell-Eggitt I, Shea SE, Davis J, Beck S, Shatirishvili G, Mihai CM, Hoeltzenbein M, Pozzan GB, Hopkinson I, Sicolo N, Naggert JK, Nishina PM (2005) New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med 165:675–683PubMed
34.
Miyata I, Vallette-Kasic S, Saveanu A, Takeuchi M, Yoshikawa H, Tajima A, Tojo K, Reynaud R, Gueydan M, Enjalbert A, Tajima N, Eto Y, Brue T (2006) Identification and functional analysis of the novel S179R POU1F1 mutation associated with combined pituitary hormone deficiency. J Clin Endoc Metab 91:4981–4987
35.
De Graaff LCG, Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K (2000) PROP1-related combined pituitary hormone deficiency. GeneReviewsSeattle (WA): University of Washington, Seattle; 1993–2014 Dec 07 (updated 2011 Oct 06)
36.
Bhangoo APS, Hunter CS, Savage JJ, Anhalt H, Pavlakis S, Walvoord EC, Ten S, Rhodes SJ (2006) Clinical case seminar: a novel LHX3 mutation presenting as combined pituitary hormonal deficiency. J Clin Endoc Metab 91:747–753
37.
Castinetti F, Saveanu A, Reynaud R, Quentien MH, Buffin A, Brauner R, Kaffel N, Albarel F, Guedj AM, El Kholy M, Amin M, Enjalbert A, Barlier A, Brue T (2008) A novel dysfunctional LHX4 mutation with high phenotypical variability in patients with hypopituitarism. J Clin Endoc Metab 93:2790–2799
38.
39.
Mullis PE (2007) Genetics of growth hormone deficiency. Endocr Metab Clin N Am 36:17–36
40.
Casey M, Vaughan CJ, He J, Hatcher CJ, Winter JM, Weremowicz S, Montgomery K, Kucherlapati R, Morton CC, Basson CT (2000) Mutations in the protein kinase A R1-alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest 106:R31–R38PubMedCentralPubMed
41.
Force American Thyroid Association Guidelines Task, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565–612
42.
Wells SA Jr, Pacini F, Robinson BG, Santoro M (2013) Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. J Clin Endocrinol Metab 98:3149–3164PubMed
43.
Romei C, Mariotti S, Fugazzola L, Taccaliti A, Pacini F, Opocher G, Mian C, Castellano M, degli Uberti E, Ceccherini I, Cremonini N, Seregni E, Orlandi F, Ferolla P, Puxeddu E, Giorgino F, Colao A, Loli P P, Bondi F, Cosci B, Bottici V, Cappai A, Pinna G, Persani L, Verga U, Boscaro M, Castagna MG, Cappelli C, Zatelli MC MC, Faggiano A, Francia G, Brandi ML ML, Falchetti A, Pinchera A, Elisei R, ItaMEN network (2010) Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol 163:301–308PubMed
44.
Ain KB (1998) Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid 8:715–726PubMed
45.
Carney JA, Gordon H, Carpenter PC, Shenoy BV (1985) The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 64:270–283
46.
Blumenthal GM, Dennis PA (2008) PTEN hamartoma tumor syndromes. Eur J Hum Gen 16:1289–1300
47.
Half E, Bercovich D, Rozen P (2009) Familial adenomatous polyposis. Orphanet J Rare Dis 12(4):22
48.
Khan A, Smellie J, Nutting C, Harrington K, Newbold K (2010) Familial nonmedullary thyroid cancer: a review of the genetics. Thyroid 20:795–801PubMed
49.
Peretz A, Leiberman E, Kapelushnik J, Hershkovitz E (2004) Thyroglossal duct carcinoma in children: case presentation and review of the literature. Thyroid 14:777–785PubMed
50.
Refetoff S, DeWind LT, DeGroot LJ (1967) Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. Clin Endocrinol Metab 27:279–294
51.
Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, Rajanayagam O, Keogh JM, Henning E, Reinemund J, Gevers E, Sarri M, Downes K, Offiah A, Albanese A, Halsall D, Schwabe JW, Bain M, Lindley K, Muntoni F, Vargha-Khadem F, Dattani M, Farooqi IS, Gurnell M, Chatterjee K (2012) A mutation in the thyroid hormone receptor alpha gene. N Engl J Med 366:243–249PubMed
52.
Schwartz CE, Ulmer J, Brown A, Pancoast I, Goodman HO, Stevenson RE (1990) Allan–Herndon syndrome. II. Linkage to DNA markers in Xq21. Am J Hum Genet 47:454–458PubMedCentralPubMed
53.
Bamforth JS, Hughes I, Lazarus J, John R (1986) Congenital anomalies associated with hypothyroidism. Arch Dis Child 61:608–609PubMedCentralPubMed
54.
Sunthornthepvarakui T, Gottschalk ME, Hayashi Y, Refetoff S (1995) Brief report: resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med 332:155–160PubMed
55.
Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17:411–422PubMed
56.
Macchia PE, Lapi P, Krude H, Pirro MT, Missero C, Chiovato L, Souabni A, Baserga M, Tassi V, Pinchera A, Fenzi G, Gruters A, Busslinger M, Di Lauro R (1998) PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet 19:83–86PubMed
57.
Devriendt K, Vanhole C, Matthijs G, de Zegher F (1998) Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. (Lett) New Eng J Med 338:1317–1318
58.
Schussler GC (2000) The thyroxine-binding proteins. Thyroid 10:141–149PubMed
59.
Fujiwara H, Tatsumi K, Miki K, Harada T, Miyai K, Takai S, Amino N (1997) Congenital hypothyroidism caused by a mutation in the Na(+)/I(−) symporter. (Letter) Nat Genet 16:124–125. (Note: Erratum: Nat Genet 17:122 only, 1997)
60.
Abramowicz MJ, Targovnik HM, Varela V, Cochaux P, Krawiec L, Pisarev MA, Propato FVE, Juvenal G, Chester HA, Vassart G (1992) Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J Clin Invest 90:1200–1204PubMedCentralPubMed
61.
Ieiri T, Cochaux P, Targovnik HM, Suzuki M, Shimoda SI, Perret J, Vassart G (1991) A 3-prime splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J Clin Invest 88:1901–1905PubMedCentralPubMed
62.
Moreno JC, Klootwijk W, van Toor H, Pinto G, D’Alessandro M, Leger A, Goudie D, Polak M, Gruters A, Visser TJ (2008) Mutations in the iodotyrosine deiodinase gene and hypothyroidism. New Eng J Med 358:1811–1818PubMed
63.
Moreno JC, Bikker H, Kempers MJE, van Trotsenburg ASP, Baas F, de Vijlder JJM, Vulsma T, Ris-Stalpers C (2002) Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. New Eng J Med 347:95–100PubMed
64.
Van Dijk FS, Pals G, Van Rijn RR, Nikkels PG, Cobben JM (2010) Classification of Osteogenesis Imperfecta revisited. Eur J Med Genet 53:1–5PubMed
65.
Marcucci G, Masi L, Carossino AM, Franchi A, Capanna R, Sinigaglia L, Brandi ML (2013) Cystic bone angiomatosis: a case report treated with aminobisphosphonates and review of the literature. Calcif Tissue Int 95:9761–9763
66.
Kiran DN, Anupama A (2011) Vanishing bone disease: a review. J Oral Maxillofac Surg 69:199–203PubMed
67.
Liberman UA, Marx SJ (2001) Vitamin D and other calciferols. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, vol II, 8th edn. McGraw-Hill, New York, pp 4223–4240
68.
Casella SJ, Reiner BJ, Chen TC, Holick MF, Harrison HE (1994) A possible genetic defect in 25-hydroxylation as a cause of rickets. J Pediatr 124:929–932PubMed
69.
Hewison M, Rut AR, Kristjansson K, Walker RE, Dillon MJ, Hughes MR, O’Riordan JL (1993) Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene. Clin Endocrinol 39:663–670
70.
Masi L, Gozzini A, Franchi A, Campanacci D, Amedei A, Falchetti A, Franceschelli F, Marcucci G, Tanini A, Capanna R, Brandi ML (2009) A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis. J Bone Jt Surg Am 91:1190–1198
71.
Hershkovitz D, Gross Y, Nahum S, Yehezkel S, Sarig O, Uitto J, Sprecher E (2011) Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis. J Invest Dermatol 131:662–669PubMedCentralPubMed
72.
Bastepe M, Jüppner H (2008) Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. Rev Endocr Metab Disord 9:171–180PubMed
73.
ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345–348
74.
White KE, Cabral JM, Davis SI, Fishburn T, Evans WE, Ichikawa S, Fields J, Yu X, Shaw NJ, McLellan NJ, McKeown C, Fitzpatrick D, Yu K, Ornitz DM, Econs MJ (2005) Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. J Hum Genet 76:361–367
75.
Brownstein CA, Adler F, Nelson-Williams C, Iijima J, Li P, Imura A, Nabeshima Y, Reyes-Mugica M, Carpenter TO, Lifton RP (2008) A translocation causing increasing α-Klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc Natl Acad Sci 105:3455–3460PubMedCentralPubMed
76.
Ihde LL, Forrester DM, Gottsegen CJ, Masih S, Patel DB, Vachon LA, White EA, Matcuk GR Jr (2011) Sclerosing bone dysplasias: review and differentiation from other causes of osteosclerosis. Radiographics 31:1865–1882PubMed
77.
Pangrazio A, Boudin E, Piters E, Damante G, Lo Iacono N, D’Elia AV, Vezzoni P, Van Hul W, Villa A, Sobacchi C (2011) Identification of the first deletion in the LRP5 gene in a patient with autosomal dominant osteopetrosis type I. Bone 49:568–571PubMedCentralPubMed
78.
Benichou OD, Laredo JD, de Vernejoul MC (2000) Type II autosomal dominant osteopetrosis (Albers-Schonberg disease): clinical and radiological manifestations in 42 patients. Bone 26:87–93PubMed
79.
Xue Y, Cai T, Shi S, Wang W, Zhang Y, Mao T, Duan X (2011) Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011. Orphanet J Rare Dis 10:6–20
80.
de Vernejoul MC (2008) Sclerosing bone disorders. Best Pract Res Clin Rheumatol 22:71–83PubMed
81.
Sheppard WM, Shprintzen RJ, Tatum SA, Woods CI (2003) Craniometaphyseal dysplasia: a case report and review of medical and surgical management. Int J Pediatr Otorhinolaryngol 67:687–693PubMed
82.
Gagliardi GG, Mahan KT (2010) Melorheostosis: a literature review and case report with surgical considerations. J Foot Ankle Surg 49:80–85PubMed
83.
Whyte MP (2008) Enzyme defects and the skeleton. In: Rosen C (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 7th edn. American Society for Bone and Mineral Research, Washington, D.C., pp 454–458
84.
Hughes AE, Ralston SH, Marken J, Bell C, MacPherson H, Wallace RG, van Hul W, Whyte MP, Nakatsuka K, Hovy L, Anderson DM (2000) Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 24:45–48PubMed
85.
Horn D, Krawitz P, Mannhardt A, Korenke GC, Meinecke P (2011) Hyperphosphatasia-mental retardation syndrome due to PIGV mutations: expanded clinical spectrum. Am J Med Genet A 155A:1917–1922PubMed
86.
Krawitz PM, Murakami Y, Hecht J, Krüger U, Holder SE, Mortier GR, Delle Chiaie B, De Baere E, Thompson MD, Roscioli T, Kielbasa S, Kinoshita T, Mundlos S, Robinson PN, Horn D (2012) Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation. Am J Hum Genet 91:146–151PubMedCentralPubMed
87.
Hansen L, Tawamie H, Murakami Y, Mang Y, ur Rehman S, Buchert R, Schaffer S, Muhammad S, Bak M, Nöthen MM, Bennett EP, Maeda Y, Aigner M, Reis A, Kinoshita T, Tommerup N, Baig SM, Abou Jamra R (2013) Hypomorphic mutations in PGAP2, encoding a GPI-anchor-remodeling protein, cause autosomal-recessive intellectual disability. Am J Hum Genet 92:575–583PubMedCentralPubMed
88.
Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, Mumm S (2002) Osteoprotegerin deficiency and juvenile Paget’s disease. N Engl J Med 347:175–184PubMed
89.
Salpea P, Stratakis CA (2014) Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics. Mol Cell Endocrinol 386:85–91PubMed
90.
Waaijer CJ, Winter MG, Reijnders CM, de Jong D, John Ham S, Bovée JV, Szuhai K (2013) Intronic deletion and duplication proximal of the EXT1 gene: a novel causative mechanism for multiple osteochondromas. Genes Chromosomes Cancer 52:431–436PubMed
91.
Francannet C, Cohen-Tanugi A, Le Merrer M, Munnich A, Bonaventure J, Legeai-Mallet L (2001) Genotype–phenotype correlation in hereditary multiple exostoses. J Med Genet 38:430–434PubMedCentralPubMed
92.
Bocciardi R, Bordo D, Di Duca M, Di Rocco M, Ravazzolo R (2009) Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Eur J Hum Genet 17:311–318PubMedCentralPubMed
93.
Marcocci C, Cetani F (2011) Clinical practice. Primary hyperparathyroidism. N Engl J Med 365:2389–2397PubMed
94.
Pepe J, Cipriani C, Pilotto R, De Lucia F, Castro C, Lenge L, Russo S, Guarnieri V, Scillitani A, Carnevale V, D’Erasmo E, Romagnoli E, Minisola S (2011) Sporadic and hereditary primary hyperparathyroidism. J Endocrinol Invest 34:40–44PubMed
95.
Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990–3011PubMed
96.
Costa-Guda J, Arnold A (2013) Genetic and epigenetic changes in sporadic endocrine tumors: Parathyroid tumors. Mol Cell Endocrinol 386:S0303–S7207PubMed
97.
Marx SJ (2011) Hyperparathyroid genes: sequences reveal answers and questions. Endocr Pract 3:18–27
98.
Pannett AAJ, Thakker RV (2001) Somatic mutations in MEN type 1 tumors, consistent with the Knudson ‘two-hit’ hypothesis. J Clin Endocrinol Metab 86:4371–4374PubMed
99.
Costa-Guda J, Arnold A (2014) Genetic and epigenetic changes in sporadic endocrine tumors: Parathyroid tumors. Mol Cell Endocrinol 386:46–54PubMed
100.
Maher ER, Richard S, Gardie B, Couvé S, Gad S (2013) Von Hippel–Lindau: how a rare disease illuminates cancer biology. Semin Cancer Biol 23:26–37
101.
Cetani F, Pardi E, Borsari S, Viacava P, Dipollina G, Cianferotti L, Ambrogini E, Gazzerro E, Colussi G, Berti P, Miccoli P, Pinchera A, Marcocci C (2004) Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89:5583–5591PubMed
102.
Egbuna OI, Brown EM (2008) Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheum 22:129–148
103.
Marcocci C, Cetani F, Rubin MR, Silverberg SJ, Pinchera A, Bilezikian J (2008) Parathyroid carcinoma. J Bone Miner Res 23:1869–1880PubMedCentralPubMed
104.
Hannan FM, Thakker RV (2013) Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism. Best Pract Res Clin Endocrinol Metab 27:359–371PubMed
105.
Nesbit MA, Hannan FM, Howles SA, Babinsky VN, Head RA, Cranston T, Rust N, Hobbs MR, Heath H 3rd, Thakker RV (2013) Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia. N Engl J Med 368:2476–2486PubMedCentralPubMed
106.
Hendy GN, Cole DE (2013) Ruling in a suspect: the role of AP2S1 mutations in familial hypocalciuric hypercalcemia type 3. J Clin Endocrinol Metab 98:4666–4669PubMedCentralPubMed
107.
Pallais JC, Kifor O, Chen YB, Slovik D, Brown EM (2004) Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. N Engl J Med 22(351):362–369
108.
Fujino T, Watanabe T, Yamaguchi K, Nagasaki K, Onishi E, Iwamoto I, Dozono H, Nagata Y (1992) The development of hypercalcemia in a patient with an ovarian tumor producing parathyroid hormone-related protein. Cancer 70:2845–2850PubMed
109.
Botea V, Edelson GW, Munasinghe RL (2003) Hyperparathyroidism, hypercalcemia, and calcified brain metastatic lesions in a patient with small cell carcinoma demonstrating positive immunostain for parathyroid hormone. Endocr Pract 9:40–44PubMed
110.
Rizzoli R, Pache JC, Didierjean L, Bürger A, Bonjour JP (1994) A thymoma as a cause of true ectopic hyperparathyroidism. J Clin Endocrinol Metab 79:912–915PubMed
111.
Brown EM (2009) Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism. Endocrinol Metab Clin N Am 38:437–445
112.
Perheentupa J (2006) Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 91:2843–2850PubMed
113.
Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM (1990) Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. J Clin Invest 86:1084–1087PubMedCentralPubMed
114.
Pollak MR, Brown EM, Estep HL, McLaine PN, Kifor O, Park J, Hebert SC, Seidman CE, Seidman JG (1994) Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet 8:303–307PubMed
115.
Thakker RV, Davies KE, Whyte MP, Wooding C, Riordan JL (1990) Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26–Xq27 by linkage studies. J Clin Invest 86:40–45PubMedCentralPubMed
116.
Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R (2003) Role of TBX1 in human del22q11.2 syndrome. Lancet 362:1366–1373PubMed
117.
Watanabe T, Mochizuki H, Kohda N, Minamitani K, Minagawa M, Yasuda T, Niimi H (1998) Autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia. Eur J Endocrinol 139:631–634PubMed
118.
Kenny FM, Linarelli L (1966) Dwarfism and cortical thickening of tubular bones. Transient hypocalcemia in a mother and son. Am J Dis Child 111:201–207PubMed
119.
Marsden D, Nyhan WL, Sakati NO (1994) Syndrome of hypoparathyroidism with growth hormone deficiency and multiple minor anomalies. Am J Med Genet 52:334–338PubMed
120.
Baruteau J, Levade T, Redonnet-Vernhet I, Mesli S, Bloom MC, Broué P (2009) Hypoketotic hypoglycemia with myolysis and hypoparathyroidism: an unusual association in medium chain acyl-CoA desydrogenase deficiency (MCADD). J Pediatr Endocrinol Metab 22:1175–1177PubMed
121.
Montagna P, Gallassi R, Medori R, Govoni E, Zeviani M, Di Mauro S, Lugaresi E, Andermann F (1998) MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology 38:751–754
122.
Spiekerkoetter U, Sun B, Khuchua Z, Bennett MJ, Strauss AW (2003) Molecular and phenotypic heterogeneity in mitochondrial trifunctional protein deficiency due to beta-subunit mutations. Hum Mutat 21:598–607PubMed
123.
Matsubara Y, Kraus JP, Yang-Feng TL, Francke U, Rosenberg LE, Tanaka K (1986) Molecular cloning of cDNAs encoding rat and human medium-chain acyl-CoA dehydrogenase and assignment of the gene to human chromosome 1. Proc Nat Acad 83:6543–6547
124.
Mantovani G, Spada A (2006) Mutations in the Gs alpha gene causing hormone resistance. Bes Prac Res Clin Endocr Metab 20:501–513
125.
Brandi ML (2011) Genetics of hypoparathyroidism and pseudohypoparathyroidism. J Endocrinol Invest 34:27–34PubMed
126.
Farfel Z, Bourne HR, Iiri T (1999) The expanding spectrum of G protein diseases. N Engl J Med 340:1012–1020PubMed
127.
Wilson LC, Oude Luttikhuis MEM, Clayton PT, Fraser WD, Trembath RC (1994) Parental origin of Gs-alpha gene mutations in Albright’s hereditary osteodystrophy. J Med Genet 31:835–839PubMedCentralPubMed
128.
Calvi LM, Schipani E (2000) The PTH/PTHrP receptor in Jansen’s metaphyseal chondrodysplasia. J Endocrinol Invest 23:545–554PubMed
129.
Tanaka H (2010) Cytokines in bone diseases. FGF receptor signaling and achondroplasia/hypochondroplasi. Clin Calcium 20:1490–1496PubMed
130.
Superti-Furga A, Spranger J, Nishimura G (2012) Enchondromatosis revisited: new classification with molecular basis. Am J Med Genet C Semin Med Genet 15:154–164
131.
Huang-Doran I, Sleigh A, Rochford JJ, O’Rahilly S, Savage DB (2010) Lipodystrophy: metabolic insights from a rare disorder. Endocrinol 207:245–255
132.
Garg A (2004) Acquired and inherited lipodystrophies. New Eng J Med 350:1220–1234PubMed
133.
Garavelli L, D’Apice MR, Rivieri F, Bertoli M, Wischmeijer A, Gelmini C, De Nigris V, Albertini E, Rosato S, Virdis R, Bacchini E, Dal Zotto R, Banchini G, Iughetti L, Bernasconi S, Superti-Furga A, Novelli GA (2009) Mandibuloacral dysplasia type A in childhood. J Med Genet A 149A:2258–2264
134.
Meas T, Laloi-Michelin M, Virally M, Ambonville C, Kevorkian JP, Guillausseau PJ (2010) Mitochondrial diabetes: clinical features, diagnosis and management. Rev Med Interne 31:216–221PubMed
135.
Marais AD, Solomon GA, Blom DJ (2014) Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E. Crit Rev Clin Lab Sci 51:46–62PubMed
136.
Wilcken Bridget (2010) Fatty acid oxidation disorders: outcome and long-term prognosis. J Inherit Metab Dis 33:501–506PubMed
137.
Thuillier L, Rostane H, Droin V, Demaugre F, Brivet M, Kadhom N, Prip-Buus C, Gobin S, Saudubray JM, Bonnefont JP (2003) Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 (CPT2) deficiency. Hum Mutat 21:493–501PubMed
138.
Lamhonwah AM, Olpin SE, Pollitt RJ, Vianey-Saban C, Divry P, Guffon N, Besley GT, Onizuka R, De Meirleir LJ, Cvitanovic-Sojat L, Baric I, Dionisi-Vici C, Fumic K, Maradin M, Tein I (2002) Novel OCTN2 mutations: no genotype–phenotype correlations: early carnitine therapy prevents cardiomyopathy. Am J Med Genet 111:271–284PubMed
139.
Bougnères PF, Saudubray JM, Marsac C, Bernard O, Odièvre M, Girard J (1981) Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediatr 98:742–746PubMed
140.
Shirao K, Okada S, Tajima G, Tsumura M, Hara K, Yasunaga S, Ohtsubo M, Hata I, Sakura N, Shigematsu Y, Takihara Y, Kobayashi M (2010) Molecular pathogenesis of a novel mutation, G108D, in short-chain acyl-CoA dehydrogenase identified in subjects with short-chain acyl-CoA dehydrogenase deficiency. Hum Genet 127:619–628PubMed
141.
Lee J, Hegele RA (2014) Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management. J Inherit Metab Dis 37:333–339PubMed
142.
Fab Schiffmann R (2009) Fabry disease. Pharmacol Ther 122:65–77
143.
Merkel M, Eckel RH, Goldberg IJ (2002) Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 43:1997–2006PubMed
144.
Mehta A (2006) Epidemiology and natural history of Gaucher’s disease. Eur J Intern Med 17:S2–S5PubMed
145.
Hicks J, Wartchow E, Mierau G (2011) Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment. Ultrastruct Pathol 35:183–196PubMed
146.
Ligon AH, Moore SD, Parisi MA, Mealiffe ME, Harris DJ, Ferguson HL, Quade BJ, Morton CC (2005) Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas. Am J Hum Genet 76:340–348PubMedCentralPubMed
147.
Kaczirek K, Niederle B (2004) Nesidioblastosis: an old term and a new understanding. World J Surg 28:1227–1230PubMed
148.
Austin MA, Hutter CM, Zimmern RL, Humphries SE (2004) Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 160:407–420PubMed
149.
Muenzer J (2011) Overview of the mucopolysaccharidose. Rheumatology 50:v4–v12PubMed
150.
Mahoney CP, Weinberger E, Bryant C, Ito M, Jameson JL, Ito M (2002) Effects of aging on vasopressin production in a kindred with autosomal dominant neurohypophyseal diabetes insipidus due to the delta-E47 neurophysin mutation. J Clin Endocrinol Metab 87:870–876PubMed
151.
Forssman H (1955) Two different mutations of the X-chromosome causing diabetes insipidus. Am J Hum Genet 7:21–27PubMedCentralPubMed
152.
Hofmann S, Philbrook C, Gerbitz KD, Bauer MF (2003) Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum Molec Genet 12:2003–2012PubMed
153.
Holtzman EJ, Harris HW Jr, Kolakowski LF Jr, Guay-Woodford LM, Botelho B, Ausiello DA (1993) Brief report: a molecular defect in the vasopressin V2-receptor gene causing nephrogenic diabetes insipidus. N Engl J Med. 328:1534–1537PubMed
154.
Deen PM, Croes H, van Aubel RA, Ginsel LA, van Os CH (1995) Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest 95:2291–2296PubMedCentralPubMed
155.
Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, Lustig RH, Mathias RS, Portale AA, Miller WL, Gitelman SE (2005) Nephrogenic syndrome of inappropriate antidiuresis. New Eng J Med 352:1884–1890PubMed
156.
Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Gomez L, Pinto M, Huete A, Oestreicher E, Foradow A, Montero J (2000) Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85:1863–1867PubMed
157.
Lafferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P, Gordon RD, Stratakis CA (2000) A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 37:831–835PubMedCentralPubMed
158.
Choi M, Scholl UI, Yue P, Bjorklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Akerstrom G, Wang W, Carling T, Lifton RP (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768–772PubMedCentralPubMed
159.
Fava C, Montagnana M, Rosberg L, Burri P, Almgren P, Jonsson A, Wanby P, Lippi G, Minuz P, Hulthen LU, Aurell M, Melander O (2008) Subjects heterozygous for genetic loss of function of the thiazide-sensitive cotransporter have reduced blood pressure. Hum Mol Genet 17:413–418PubMed
160.
Deschenes G, Burguet A, Guyot C, Hubert P, Garabedian M, Dechaux M, Loirat C, Broyer M (1993) Forme antenatale de syndrome de Bartter. Ann Pediat 40:95–101PubMed
161.
Finer G, Shalev H, Birk OS, Galron D, Jeck N, Sinai-Treiman L, Landau D (2003) Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome. J Pediat 142:318–323PubMed
162.
Nozu K, Inagaki T, Fu XJ, Nozu Y, Kaito H, Kanda K, Sekine T, Igarashi T, Nakanishi K, Yoshikawa N, Iijima K, Matsuo M (2008) Molecular analysis of digenic inheritance in Bartter syndrome with sensorineural deafness. J Med Genet 45:182–186PubMed
163.
Arant BS, Brackett NC Jr, Young RB, Still WJS (1970) Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal rickets—Bartter’s syndrome or disease? Pediatrics 46:344–361PubMed
164.
Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP (1994) Liddle’s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79:407–414PubMed
165.
Mansfield TA, Simon DB, Farfel Z, Bia M, Tucci JR, Lebel M, Gutkin M, Vialettes B, Christofills MA, Kauppinen-Makelin R, Mayan H, Risch N, Lifton RP (1997) Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromose 1q31-42 and 17p11-q21. Nat Genet 16:202–205PubMed
166.
Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez C, Rauh W, Rosler A, Bradlow HL, New MI (1979) A syndrome of apparent mineralocorticoid excess asociated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 49:757–764PubMed
167.
Gimenez-Roqueplo AP, Dahia PL, Robledo M (2012) An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res 44:328–333PubMed
168.
Bausch B, Borozdin W, Mautner VF, Hoffmann MM, Boehm D, Robledo M, Cascon A, Harenberg T, Schiavi F, Pawlu C, Peczkowska M, Letizia C, Calvieri S, Arnaldi G, Klingenberg-Noftz RD, Reisch N, Fassina A, Brunaud L, Walter MA, Mannelli M, MacGregor G, Palazzo FF, Barontini M, Walz MK, Kremens B, Brabant G, Pfäffle R, Koschker AC, Lohoefner F, Mohaupt M, Gimm O, Jarzab B, McWhinney SR, Opocher G, Januszewicz A, Kohlhase J, Eng C, Neumann HP, European-American Phaeochromocytoma Registry Study Group (2007) Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab 92:2784–2792PubMed
169.
Yao L, Schiavi F, Cascon A, Qin Y, Inglada-Pérez L, King EE, Toledo RA, Ercolino T, Rapizzi E, Ricketts CJ, Mori L, Giacchè M, Mendola A, Taschin E, Boaretto F, Loli P, Iacobone M, Rossi GP, Biondi B, Lima-Junior JV, Kater CE, Bex M, Vikkula M, Grossman AB, Gruber SB, Barontini M, Persu A, Castellano M, Toledo SP, Maher ER, Mannelli M, Opocher G, Robledo M, Dahia PL (2010) Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. JAMA 304:2611–2619PubMed
170.
Burnichon N, Cascón A, Schiavi F, Morales NP, Comino-Méndez I, Abermil N, Inglada-Pérez L, de Cubas AA, Amar L, Barontini M, de Quirós SB, Bertherat J, Bignon YJ, Blok MJ, Bobisse S, Borrego S, Castellano M, Chanson P, Chiara MD, Corssmit EP, Giacchè M, de Krijger RR, Ercolino T, Girerd X, Gómez-García EB, Gómez-Graña A, Guilhem I, Hes FJ, Honrado E, Korpershoek E, Lenders JW, Letón R, Mensenkamp AR, Merlo A, Mori L, Murat A, Pierre P, Plouin PF, Prodanov T, Quesada-Charneco M, Qin N, Rapizzi E, Raymond V, Reisch N, Roncador G, Ruiz-Ferrer M, Schillo F, Stegmann AP, Suarez C, Taschin E, Timmers HJ, Tops CM, Urioste M, Beuschlein F, Pacak K, Mannelli M, Dahia PL, Opocher G, Eisenhofer G, Gimenez-Roqueplo AP, Robledo M (2012) MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res 18:2828–2837PubMed
171.
Gimenez-Roqueplo AP, Caumont-Prim A, Houzard C, Hignette C, Hernigou A, Halimi P, Niccoli P, Leboulleux S, Amar L, Borson-Chazot F, Cardot-Bauters C, Delemer B, Chabolle F, Coupier I, Libé R, Peitzsch M, Peyrard S, Tenenbaum F, Plouin PF, Chatellier G, Rohmer V (2013) Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL. EVA Investigators. J Clin Endocrinol Metab 98:E162–E173PubMed
172.
Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, Devilee P, Cremers CW, Schiffman JD, Bentz BG, Gygi SP, Winge DR, Kremer H, Rutter J (2009) SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325:1139–1142PubMed
173.
Niemann S, Müller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26:268–270PubMed
174.
Carney JA, Stratakis CA (2002) Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am J Med Genet 108:132–139PubMed
175.
Carney JA (1999) Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, an possible familial occurrence. Mayo Clin Proc 74:543–552PubMed
176.
White PC, Speiser PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245–291PubMed
177.
Joehrer K, Geley S, Strasser-Wozak EM, Azziz R, Wollmann HA, Schmitt K, Kofler R, White PC (1997) CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 β-hydroxylase deficiency. Hum Mol Genet 6:1829–1834PubMed
178.
Auchus RJ (2001) The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin N Am 30:101–119
179.
Simard J, Ricketts ML, Gingras S, Soucy P, Feltus FA, Melner MH (2005) Molecular biology of the 3β-hydroxysteroid dehydrogenase/δ5–δ4 isomerase gene family. Endocr Rev 26:525–582PubMed
180.
Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM, Stewart PM, Shackleton CHL (2004) Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363:2128–2135PubMed
181.
Bose HS, Sugawara T, Strauss JF, Miller WL (1996) The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International congenital lipoid adrenal hyperplasia consortium. N Engl J Med 335:1870–1878PubMed
182.
Kim CJ, Lin L, Huang N, Quigley CA, AvRuskin TW, Achermann JC, Miller WL (2008) Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. J Clin Endocrinol Metab 93:696–702PubMedCentralPubMed
183.
Bertagna X, Guignat L (2013) Approach to the Cushing’s disease patient with persistent/recurrent hypercortisolism after pituitary surgery. J Clin Endocrinol Metab 98:1307–1318PubMed
184.
Stratakis CA, Bertherat J, Carney JA (2004) Mutation of perinatal myosin heavy chain. N Engl J Med 351:2556–2558PubMed
185.
Libé R, Horvath A, Vezzosi D, Fratticci A, Coste J, Perlemoine K, Ragazzon B, Guillaud-Bataille M, Groussin L, Clauser E, Raffin-Sanson ML, Siegel J, Moran J, Drori-Herishanu L, Faucz FR, Lodish M, Nesterova M, Bertagna X, Bertherat J, Stratakis CA (2011) Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype. J Clin Endocrinol Metab 96:E208–E214PubMedCentralPubMed
186.
Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, Eden OB, Varley JM (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20:4621–4628PubMed
187.
Vahteristo P, Tamminen A, Karvinen P, Eerola H, Eklund C, Aaltonen LA, Blomqvist C, Aittomaki K, Nevanlinna H (2001) p53, CHK2, and CHK1 genes in Finnish families with Li–Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Cancer Res 61:5718–5722PubMed
188.
Bachinski LL, Olufemi SE, Zhou X, Wu CC, Yip L, Shete S, Lozano G, Amos CI, Strong LC, Krahe R (2005) Genetic mapping of a third Li–Fraumeni syndrome predisposition locus to human chromosome 1q23. Cancer Res 65:427–431PubMed
189.
Eggermann T, Algar E, Lapunzina P, Mackay D, Maher ER, Mannens M, Netchine I, Prawitt D, Riccio A, Temple IK, Weksberg R (2014) Clinical utility gene card for: Beckwith–Wiedemann syndrome. Eur J Hum Genet. doi:10.​1038/​ejhg.​2013.​132
190.
Christopoulos S, Bourdeau I, Lacroix A (2005) Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors. Horm Res 64:119–131PubMed
191.
Tadjine M, Lampron A, Ouadi L, Horvath A, Stratakis CA, Bourdeau I (2008) Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD). Clin Endocrinol (Oxf) 69:367–373
192.
Arlt W, Allolio B (2003) Adrenal insufficiency. Lancet 361:1881–1893PubMed
193.
Lalli E, Sassone-Corsi P (1999) DAX-1 and the adrenal cortex. Curr Opin Endocrinol Metab 6:185–190
194.
Laureti S, Casucci G, Santeusanio F, Angeletti G, Aubourg P, Brunetti P (1996) X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison’s disease in young adult male patients. J Clin Endocrinol Metab 81:470–474PubMed
195.
Metherell LA, Chapple JP, Cooray S, David A, Becker C, Rüschendorf F, Naville D, Begeot M, Khoo B, Nürnberg P, Huebner A, Cheetham ME, Clarket AJL (2005) Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet 37:166–170PubMed
196.
Gicquel C, Le Bouc Y, Luton JP, Bertagna X (1998) Pathogenesis and treatment of adrenocortical carcinoma. Curr Opin Endocrinol Diab 5:189–196
197.
Gonzalez L, Witchel S-F (2012) The patient with Turner syndrome: puberty and medical management concerns. Fertil Steril 98:780–786PubMedCentralPubMed
198.
Agarwal P, Philip R, Gutch M, Gupta KK (2013) The other side of Turner’s: Noonan’s syndrome. Indian J Endocrinol Metab 17:794–798PubMedCentralPubMed
199.
Rafique S, Sterling EW, Nelson LM (2012) A new approach to primary ovarian insufficiency. Obstet Gynecol Clinc N Am 39:567–586
200.
Kousta E, Papathanasiou A, Skordis N (2010) Sex determination and disorders of sex development according to the revised nomenclature and classification in 46, XX individuals. Hormones (Athens) 9:218–231
201.
Young RH, Scully RE (1985) Ovarian Sertoli–Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 9:543–569PubMed
202.
Young RH, Dickersin GR, Scully RE (1984) Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol 8:575–596PubMed
203.
Stettner AR, Hartenbach EM, Schink JC, Huddart R, Becker J, Pauli R, Long R, Laxova R (1999) A Familial ovarian germ cell cancer: report and review. J Med Genet 7:43–46
204.
Vorona E, Zitzmann M, Gromoll J, Schüring AN, Nieschlag E (2007) Clinical, endocrinological, and epigenetic features of the 46, XX male syndrome, compared with 47, XXY Klinefelter patients. J Clin Endocrinol Metab 92:3458–3465PubMed
205.
Udd B, Krahe R (2012) The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 11:891–905PubMed
206.
Latronico AC, Arnhold IJ (2012) Inactivating mutations of the human luteinizing hormone receptor in both sexes. Semin Reprod Med 30:382–386PubMed
207.
Latronico AC, Arnhold IJ (2013) Gonadotropin resistance. Endocr Dev 24:25–32PubMed
208.
Kemp S, Berger J, Aubourg P (2012) X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta 1822:1465–1474PubMed
209.
210.
Ferlin A, Arredi B, Speltra E, Cazzadore C, Selice R, Garolla A, Lenzi A, Foresta C (2007) Molecular and clinical characterization of Y chromosome microdeletions in infertile men: a 10-year experience in Italy. J Clin Endocrinol Metab 9:762–770
211.
Toledo SPA (1992) Leydig cell hypoplasia leading to two different phenotypes: male pseudohermaphroditism and primary hypogonadism not associated with this. (Lett) Clin Endocr 36:521–522
212.
Nowaczyk MJ, Irons MB (2012) Smith-Lemli–Opitz syndrome: phenotype, natural history, and epidemiology. Am J Med Genet C Semin Med Genet 160C:250–262PubMed
213.
King SR, Bhangoo A, Stocco DM (2011) Functional and physiological consequences of StAR deficiency: role in lipoid congenital adrenal hyperplasia. Endocr Dev 20:47–53PubMed
214.
Hiort O, Holterhus PM, Werner R, Marschke C, Hoppe U, Partsch CJ, Riepe FG, Achermann JC, Struve D (2005) Homozygous disruption of P450 side-chain cleavage (CYP11A1) is associated with prematurity, complete 46, XY sex reversal, and severe adrenal failure. J Clin Endocrinol Metab 90:538–541PubMed
215.
Krone N, Arlt W (2009) Genetics of congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 23:181–192PubMed
216.
George MM, New MI, Ten S, Sultan C, Bhangoo A (2010) The clinical and molecular heterogeneity of 17βHSD-3 enzyme deficiency. Horm Res Paediatr 74:229–240PubMed
217.
Costa EM, Domenice S, Sircili MH, Inacio M, Mendonca BB (2012) DSD due to 5α-reductase 2 deficiency—from diagnosis to long term outcome. Semin Reprod Med 30:427–431PubMed
218.
Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J (2012) Androgen insensitivity syndrome. Lancet 380:1419–1428PubMed
219.
Hughes IA, Werner R, Bunch T, Hiort O (2012) Androgen insensitivity syndrome. Semin Reprod Med 30:432–442PubMed
220.
Monks DA, Rao P, Mo K, Johansen JA, Lewis G, Kemp MQ (2008) Androgen receptor and Kennedy disease/spinal bulbar muscular atrophy. Horm Behav 53:729–740PubMedCentralPubMed
221.
Massanyi EZ, Dicarlo HN, Migeon CJ, Gearhart JP (2013) Review and management of 46, XY disorders of sex development. J Pediatr Urol 9:368–379PubMed
222.
Ferraz-de-Souza B, Lin L, Achermann JC (2011) Steroidogenic factor-1 (SF-1, NR5A1) and human disease. Mol Cell Endocrinol 336:198–205PubMedCentralPubMed
223.
Mendonca BB, Domenice S, Arnhold IJ, Costa EM (2009) 46, XY disorders of sex development (DSD). Clin Endocrinol (Oxf) 70:173–187
224.
Foster JW (1996) Mutations in SOX9 cause both autosomal sex reversal and campomelic dysplasia. Acta Paediatr Jpn 38:405–411PubMed
225.
Koziell A, Charmandari E, Hindmarsh PC, Rees L, Scambler P, Brook CG (2000) Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy? Clin Endocrinol (Oxf) 52:519–524
226.
Baets J, Dierick I, Groote CC, Ende JV, Martin JJ, Geens K, Robberecht W, Nelis E, Timmerman V, Jonghe PD (2009) Peripheral neuropathy and 46XY gonadal dysgenesis: a heterogeneous entity. Neuromuscul Disord 19:172–175PubMed
227.
Horwich A, Nicol D, Huddart R (2013) Testicular germ cell tumours. BMJ 347:f5526PubMed
228.
Olivier P, Simoneau-Roy J, Francoeur D, Sartelet H, Parma J, Vassart G, Van Vliet G (2012) Leydig cell tumors in children: contrasting clinical, hormonal, anatomical, and molecular characteristics in boys and girls. J Pediatr 161:1147–1152PubMed
229.
Gómez García I, Romero Molina M, López-García Moreno A, Buendía González E, Rubio Hidalgo E, Bolufer E, Sampietro Crespo A, Gómez Rodríguez A (2010) Sertoli cell tumor, a rare testicular tumor, our experience and review of the literature. Arch Esp Urol 63:392–395PubMed
230.
231.
Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Lancet 372:657–668PubMed
232.
Jadhav U, Harris RM, Jameson JL (2011) Hypogonadotropic hypogonadism in subjects with DAX1 mutations. Mol Cell Endocrinol 346:65–73PubMedCentralPubMed
233.
Rothenbuhler A, Stratakis CA (2010) Clinical and molecular genetics of Carney complex. Best Pract Res Clin Endocrinol Metab 24:389–399PubMed
234.
Weiler FG, Dias-da-Silva MR, Lazaretti-Castro M (2012) Autoimmune polyendocrine syndrome type 1: case report and review of literature. Arq Bras Endocrinol Metabol 56:54–66PubMed
235.
Proust-Lemoine E, Saugier-Veber P, Wémeau JL (2012) Polyglandular autoimmune syndrome type I. Presse Med 41:e651–e662PubMed
236.
Betterle C, Zanchetta R (2003) Update on autoimmune polyendocrine syndromes (APS). Acta Biomed 74:9–33PubMed
237.
Michels AW, Gottlieb PA (2010) Autoimmune polyglandular syndromes. Nat Rev Endocrinol 6:270–277PubMed
238.
Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ (2008) Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg 12:382–393PubMed
239.
Kanakis G, Kaltsas G (2012) Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs). Best Pract Res Clin Gastroenterol 26:791–802PubMed
240.
Nesi G, Marcucci T, Rubio CA, Brandi ML, Tonelli F (2008) Somatostatinoma: clinico-pathological features of three cases and literature reviewed. J Gastroenterol Hepatol 23:521–526PubMed
241.
Eldor R, Glaser B, MeravFraenkel M, Doviner V, Salmon A, Gross DJ (2011) Glucagonoma and the glucagonoma syndrome—cumulative experience with an elusive endocrine tumour. Clin Endocrinol 74:593–598
242.
Balachandran A, Tamm EP, Bhosale PR, Patnana M, Vikram R, Fleming JB, Katz MH, Charnsangavej C (2013) Pancreatic neuroendocrine neoplasms: diagnosis and management. Abdom Imaging 38:342–357PubMed
243.
Amador Cano A, García F, Espinoza A, Bezies N, Herrera H, De Leija Portilla J (2013) Nonfunctional neuroendocrine tumor of the pancreas: case report and review of the literature. Int J Surg Case Rep 4:225–228PubMedCentralPubMed
244.
Faggiano A, Ferolla P, Grimaldi F, Campana D, Manzoni M, Davì MV, Bianchi A, Valcavi R, Papini E, Giuffrida D, Ferone D, Fanciulli G, Arnaldi G, Franchi GM, Francia G, Fasola G, Crinò L, Pontecorvi A, Tomassetti P, Colao A (2012) Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study. J Endocrinol Invest 35:817–823PubMed
245.
Gibril F, Jensen RT (2005) Advances in valuation and management of gastrinoma in patients with Zollinger–Ellison syndrome. Curr Gastroenterol Rep 7:114–121PubMed
246.
O’Toole D, Delle Fave G, Jensen RT (2012) Gastric and duodenal neuroendocrine tumours. Best Pract Res Clin Gastroenterol 26:719–735PubMed
247.
Fraenkel M, Kim MK, Tonelli F, Giudici F, Giusti F, Brand ML (2012) Gastroenteropancreatic neuroendocrine tumors in multiple endocrine neoplasia Type 1. Cancers 4:504–522
248.
Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, Service FJ (2009) Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical practice guideline. J Clin Endocrinol Metab 94:709–728PubMed
249.
Strosberg J (2012) Neuroendocrine tumours of the small intestine. Best Practice Res Clin Gastroenterol 26:755–773
250.
Mandair D, Caplin ME (2012) Colonic and rectal NET’s. Best Practice Res Clin Gastroenterol 26:775–789
251.
Francis JM, Kiezun A, Ramos AH, Serra S, SekharPedamallu C, Qian ZR, Banck MS, Kanwar R, Kulkarni AA, Karpathakis A, Manzo V, Contractor T, Philips J, Nickerson E, Pho N, Hooshmand SM, Brais LK, Lawrence MS, Pugh T, McKenna A, Sivachenko A, Cibulskis K, Carter SL, Ojesina AI, Freeman S, Jones RT, Voet D, Auclair D, Saksena G, Onofrio R, Shefler E, Sougnez C, Grimsby J, Green L, Lennon N, Meyer T, Caplin M, Chung DC, Beutler AS, Ogino S, Thirlwell C, Shivdasani R, Asa SL, Harris CR, Getz G, Kulke M, Meyerson M (2013) Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. Nat Genet 45:12
252.
Chopin-Laly X, Walter T, Hervieu V, Poncet G, Adham M, Guibal A, Chayvialle JA, Lombard-Bohas C, Scoazec GY (2013) Neuroendocrine neoplasms of the jejunum: a heterogeneous group with distinctive proximal and distal subsets. Virchows Arch 462:489–499PubMed
253.
Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE (2010) Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol 37:20–27PubMed
Metadaten
Titel
Rare diseases in clinical endocrinology: a taxonomic classification system
verfasst von
G. Marcucci
L. Cianferotti
P. Beck-Peccoz
M. Capezzone
F. Cetani
A. Colao
M. V. Davì
E. degli Uberti
S. Del Prato
R. Elisei
A. Faggiano
D. Ferone
C. Foresta
L. Fugazzola
E. Ghigo
G. Giacchetti
F. Giorgino
A. Lenzi
P. Malandrino
M. Mannelli
C. Marcocci
L. Masi
F. Pacini
G. Opocher
A. Radicioni
M. Tonacchera
R. Vigneri
M. C. Zatelli
M. L. Brandi
Publikationsdatum
01.02.2015
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 2/2015
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-014-0202-6

Weitere Artikel der Ausgabe 2/2015

Journal of Endocrinological Investigation 2/2015 Zur Ausgabe

Thanks to Reviewers

Thanks to Reviewers 2014

Rapid Communication

Incidence of congenital hypothyroidism in the Autonomous Province of Bolzano: benefit of increased iodine intake

Original Article

GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution

Original Article

Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naïve type 2 diabetic patients

Original Article

Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves’ orbitopathy

Original Article

Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise